PlainRecalls
FDA Drug Moderate Class II Terminated

Doxycycline Hyclate Tablets, USP, 100 mg, 50-count carton (10 tablets each blister pack x 5), Rx only, MFG: Major Pharma, NDC 0904-0430-06

Reported: June 15, 2022 Initiated: April 13, 2022 #D-1054-2022

Product Description

Doxycycline Hyclate Tablets, USP, 100 mg, 50-count carton (10 tablets each blister pack x 5), Rx only, MFG: Major Pharma, NDC 0904-0430-06

Reason for Recall

cGMP deviations: Temperature abuse

Details

Units Affected
108 cartons/50 blisters per carton
Distribution
USA nationwide.
Location
Richmond, VA

Frequently Asked Questions

What product was recalled?
Doxycycline Hyclate Tablets, USP, 100 mg, 50-count carton (10 tablets each blister pack x 5), Rx only, MFG: Major Pharma, NDC 0904-0430-06. Recalled by Mckesson Medical-Surgical Inc. Corporate Office. Units affected: 108 cartons/50 blisters per carton.
Why was this product recalled?
cGMP deviations: Temperature abuse
Which agency issued this recall?
This recall was issued by the FDA Drug on June 15, 2022. Severity: Moderate. Recall number: D-1054-2022.